Yochi Slonim, Anima Biotech CEO
January 10, 2023 01:43 PM EST
Deals
AI

Ab­b­Vie signs mR­NA pact with An­i­ma Biotech for $42M up­front

Katherine Lewin

News Reporter

Ab­b­Vie is part­ner­ing on mR­NA, hop­ing to de­vel­op new med­i­cines with the help of a small biotech’s tech­nol­o­gy plat­form, the com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

A service from the Financial Times